S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
The gold catalyst we've waited for (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
The gold catalyst we've waited for (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
The gold catalyst we've waited for (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
The gold catalyst we've waited for (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
NASDAQ:DCTH

Delcath Systems (DCTH) Stock Forecast, Price & News

$4.05
-0.06 (-1.46%)
(As of 09/29/2023 ET)
Compare
Today's Range
$4.03
$4.34
50-Day Range
$3.12
$5.75
52-Week Range
$2.34
$7.99
Volume
240,887 shs
Average Volume
373,769 shs
Market Capitalization
$61.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00

Delcath Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
344.4% Upside
$18.00 Price Target
Short Interest
Healthy
4.88% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.28mentions of Delcath Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$50,640 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.13) to ($1.20) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Medical Sector

86th out of 972 stocks

Surgical & Medical Instruments Industry

12th out of 98 stocks


DCTH stock logo

About Delcath Systems (NASDAQ:DCTH) Stock

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

DCTH Price History

DCTH Stock News Headlines

Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
Where Delcath Systems Stands With Analysts
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
Insider Buys Additional US$51k In Delcath Systems Stock
Analyst Expectations for Delcath Systems's Future
Why Is Delcath Systems (DCTH) Stock Up 72% Today?
See More Headlines
Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

DCTH Company Calendar

Last Earnings
8/09/2023
Today
9/30/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DCTH
Employees
52
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$21.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+344.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-36,510,000.00
Net Margins
-1,258.21%
Pretax Margin
-1,272.32%

Debt

Sales & Book Value

Annual Sales
$2.64 million
Book Value
($0.58) per share

Miscellaneous

Free Float
12,053,000
Market Cap
$61.87 million
Optionable
Not Optionable
Beta
0.75
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Gerard J. Michel MBAMr. Gerard J. Michel MBA (Age 60)
    MS, CEO & Director
    Comp: $671.6k
  • Mr. John  Purpura M.S.Mr. John Purpura M.S. (Age 62)
    Chief Operating Officer
    Comp: $485.92k
  • Dr. Johnny John M.D. (Age 59)
    Sr. VP Clinical Devel. & Medical Affairs
    Comp: $472.16k
  • Ms. Sandra Pennell (Age 43)
    Sr. VP of Fin. and Principal Financial & Accounting Officer
  • Mr. David Hoffman
    Gen. Counsel, Corp. Sec. & Chief Compliance Officer
  • Dr. Vojislav Vukovic M.D. (Age 56)
    Ph.D., Chief Medical Officer













DCTH Stock - Frequently Asked Questions

Should I buy or sell Delcath Systems stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DCTH shares.
View DCTH analyst ratings
or view top-rated stocks.

What is Delcath Systems' stock price forecast for 2023?

4 Wall Street analysts have issued 1-year price targets for Delcath Systems' stock. Their DCTH share price forecasts range from $13.00 to $21.00. On average, they predict the company's stock price to reach $18.00 in the next twelve months. This suggests a possible upside of 344.4% from the stock's current price.
View analysts price targets for DCTH
or view top-rated stocks among Wall Street analysts.

How have DCTH shares performed in 2023?

Delcath Systems' stock was trading at $3.60 at the beginning of the year. Since then, DCTH shares have increased by 12.5% and is now trading at $4.05.
View the best growth stocks for 2023 here
.

Are investors shorting Delcath Systems?

Delcath Systems saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 744,900 shares, a decline of 22.2% from the August 31st total of 957,700 shares. Based on an average trading volume of 2,190,000 shares, the days-to-cover ratio is currently 0.3 days.
View Delcath Systems' Short Interest
.

When is Delcath Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our DCTH earnings forecast
.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) released its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.58) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.09. The firm had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.73 million.

When did Delcath Systems' stock split?

Delcath Systems's stock reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What is Delcath Systems' stock symbol?

Delcath Systems trades on the NASDAQ under the ticker symbol "DCTH."

How do I buy shares of Delcath Systems?

Shares of DCTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Delcath Systems' stock price today?

One share of DCTH stock can currently be purchased for approximately $4.05.

How much money does Delcath Systems make?

Delcath Systems (NASDAQ:DCTH) has a market capitalization of $61.87 million and generates $2.64 million in revenue each year. The company earns $-36,510,000.00 in net income (profit) each year or ($3.13) on an earnings per share basis.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The official website for the company is delcath.com. The company can be reached via phone at 212-489-2100, via email at investorrelations@delcath.com, or via fax at 212-489-2102.

This page (NASDAQ:DCTH) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -